- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2057-3804
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Carfilzomib induced cardiotoxicity in a multiple myeloma patient ; volume:6 ; number:1 ; day:7 ; month:9 ; year:2020 ; pages:1-4 ; date:12.2020
Cardio-Oncology ; 6, Heft 1 (7.9.2020), 1-4, 12.2020
- Creator
-
Méndez-Toro, Arnold
Díaz-Brochero, Cándida
Acosta-Gutiérrez, Estivalis
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-020-00074-8
- URN
-
urn:nbn:de:101:1-2020102718205658180981
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Méndez-Toro, Arnold
- Díaz-Brochero, Cándida
- Acosta-Gutiérrez, Estivalis
- SpringerLink (Online service)
Other Objects (12)
Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity
Bortezomib-Induced Perimyocarditis in a Multiple Myeloma Patient: A Case Report
Multiple myeloma
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Inflammation in Chemotherapy-Induced Cardiotoxicity
Recurrent Infections in a Patient with Multiple Myeloma
Imaging of Multiple Myeloma
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
Assessment tools for patient-reported outcomes in multiple myeloma
Hemorrhagic bullous colitis in a patient with multiple myeloma
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance
Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity
Bortezomib-Induced Perimyocarditis in a Multiple Myeloma Patient: A Case Report
Multiple myeloma
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Inflammation in Chemotherapy-Induced Cardiotoxicity
Recurrent Infections in a Patient with Multiple Myeloma
Imaging of Multiple Myeloma
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
Assessment tools for patient-reported outcomes in multiple myeloma
Hemorrhagic bullous colitis in a patient with multiple myeloma
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance
Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity
Bortezomib-Induced Perimyocarditis in a Multiple Myeloma Patient: A Case Report
Multiple myeloma
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Inflammation in Chemotherapy-Induced Cardiotoxicity
Recurrent Infections in a Patient with Multiple Myeloma
Imaging of Multiple Myeloma
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
Assessment tools for patient-reported outcomes in multiple myeloma
Hemorrhagic bullous colitis in a patient with multiple myeloma